A Cofactor of tRNA Synthetase, p43, Is Secreted to Up-regulate Proinflammatory Genes*

An auxiliary factor of mammalian multi-aminoacyl-tRNA synthetases, p43, is thought to be a precursor of endothelial monocyte-activating polypeptide II (EMAP II) that triggers proinflammation in leukocytes and macrophages. In the present work, however, we have shown that p43 itself is specifically secreted from intact mammalian cells, while EMAP II is released only when the cells are disrupted. Secretion of p43 was also observed when its expression was increased. These results suggest that p43 itself should be a real cytokine secreted by an active mechanism. To determine the cytokine activity and active domain of p43, we investigated tumor necrosis factor (TNF) and interleukin-8 (IL-8) production from human monocytic THP-1 cells treated with various p43 deletion mutants. The full length of p43 showed higher cytokine activity than EMAP II, further supporting p43 as the active cytokine. p43 was also shown to activate MAPKs and NFκB, and to induce cytokines and chemokines such as TNF, IL-8, MCP-1, MIP-1α, MIP-1β, MIP-2α, IL-1β, and RANTES. Interestingly, the high level of p43 was observed in the foam cells of atherosclerotic lesions. Therefore, p43 could be a novel mediator of atherosclerosis development as well as other inflammation-related diseases.

[1]  P. Groot,et al.  Chemokines and atherosclerosis. , 1999, Atherosclerosis.

[2]  S. Libutti,et al.  Characterization of a novel tumor-derived cytokine. Endothelial-monocyte activating polypeptide II. , 1994, The Journal of biological chemistry.

[3]  M. Hofker,et al.  Scavenging new insights into atherogenesis. , 2000, The Journal of clinical investigation.

[4]  P. Vandenabeele,et al.  The endothelial monocyte‐activating polypeptide II (EMAP II) is a substrate for caspase‐7 , 2000, FEBS letters.

[5]  K. Shiba,et al.  Precursor of Pro-apoptotic Cytokine Modulates Aminoacylation Activity of tRNA Synthetase* , 1999, The Journal of Biological Chemistry.

[6]  P. Familletti,et al.  Endothelial monocyte-activating polypeptide II. A novel tumor-derived polypeptide that activates host-response mechanisms. , 1992, The Journal of biological chemistry.

[7]  W. Kisiel,et al.  A peptide derived from the amino terminus of endothelial-monocyte-activating polypeptide II modulates mononuclear and polymorphonuclear leukocyte functions, defines an apparently novel cellular interaction site, and induces an acute inflammatory response. , 1994, The Journal of biological chemistry.

[8]  H. Schluesener,et al.  Effects of autoantigen and dexamethasone treatment on expression of endothelial-monocyte activating polypeptide II and allograft-inflammatory factor-1 by activated macrophages and microglial cells in lesions of experimental autoimmune encephalomyelitis, neuritis and uveitis , 1999, Acta Neuropathologica.

[9]  H. Weiner,et al.  Resistance to Experimental Autoimmune Encephalomyelitis in Mice Lacking the Cc Chemokine Receptor (Ccr2) , 2000, The Journal of experimental medicine.

[10]  D. Baltimore,et al.  I kappa B: a specific inhibitor of the NF-kappa B transcription factor. , 1988, Science.

[11]  P. Schimmel,et al.  Two distinct cytokines released from a human aminoacyl-tRNA synthetase. , 1999, Science.

[12]  H. Schluesener,et al.  Localization of endothelial‐monocyte‐activating polypeptide II (EMAP II), a novel proinflammatory cytokine, to lesions of experimental autoimmune encephalomyelitis, neuritis and uveitis: Expression by monocytes and activated microglial cells , 1997, Glia.

[13]  M. Mirande,et al.  The p43 Component of the Mammalian Multi-synthetase Complex Is Likely To Be the Precursor of the Endothelial Monocyte-activating Polypeptide II Cytokine* , 1997, The Journal of Biological Chemistry.

[14]  J. Carmichael,et al.  Prostate adenocarcinoma cells release the novel proinflammatory polypeptide EMAP-II in response to stress. , 2000, Cancer research.

[15]  S. Libutti,et al.  Endothelial monocyte-activating polypeptide II, a tumor-derived cytokine that plays an important role in inflammation, apoptosis, and angiogenesis. , 2000, Journal of immunotherapy.

[16]  J. Warrington,et al.  The Cytokine Portion of p43 Occupies a Central Position within the Eukaryotic Multisynthetase Complex* , 2000, The Journal of Biological Chemistry.

[17]  P. Vandenabeele,et al.  Inhibition of apoptosis induced by ischemia-reperfusion prevents inflammation. , 1999, The Journal of clinical investigation.

[18]  Stuart K. Calderwood,et al.  HSP70 stimulates cytokine production through a CD14-dependant pathway, demonstrating its dual role as a chaperone and cytokine , 2000, Nature Medicine.

[19]  W. Risau,et al.  Regulation of endothelial monocyte-activating polypeptide II release by apoptosis. , 1998, Proceedings of the National Academy of Sciences of the United States of America.

[20]  B. Finlay,et al.  An α-Helical Cationic Antimicrobial Peptide Selectively Modulates Macrophage Responses to Lipopolysaccharide and Directly Alters Macrophage Gene Expression1 , 2000, The Journal of Immunology.

[21]  M. Schwarz,et al.  Temporo‐spatial distribution of endothelial‐monocyte activating polypeptide II, an anti‐angiogenic protein, in the mouse embryo , 2000, Developmental dynamics : an official publication of the American Association of Anatomists.

[22]  G C Overton,et al.  The genetic program of hematopoietic stem cells. , 2000, Science.

[23]  R. Dziarski,et al.  Chemokines Are the Main Proinflammatory Mediators in Human Monocytes Activated by Staphylococcus aureus, Peptidoglycan, and Endotoxin* , 2000, The Journal of Biological Chemistry.

[24]  L Steinman,et al.  Multiple Sclerosis: A Coordinated Immunological Attack against Myelin in the Central Nervous System , 1996, Cell.

[25]  J. Shin,et al.  A novel anti-tumor cytokine contains an RNA binding motif present in aminoacyl-tRNA synthetases. , 2000, The Journal of biological chemistry.

[26]  B. Williams,et al.  Identification of genes differentially regulated by interferon α, β, or γ using oligonucleotide arrays , 1998 .

[27]  D. Söll,et al.  Aminoacyl-tRNA synthesis. , 2000, Annual review of biochemistry.